INO Inovio Pharmaceuticals beats Q4 2025 earnings estimates by wide margin shares gain 132 percent today REFR Research shares fall 396 following Q2 2025 earnings release with no analyst consensus estimates available Cadiz CDZI Industry Outlook Cadiz sees 89 EPS miss widerthanexpected loss The valuation impact of Pursuit PRSU earnings quality Pursuit Posts 98 EPS Miss On Seasonal Headwinds